RC1 CA146299/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2010	1
2011	2
2012	6
2013	8
2014	2
2015	8
2016	10
2017	14
2018	6
2019	2
2020	5
2021	2
2022	1
2023	3
2024	0

1

PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.

Xu-Monette ZY, Zhou J, Young KH. Xu-Monette ZY, et al. Blood. 2018 Jan 4;131(1):68-83. doi: 10.1182/blood-2017-07-740993. Epub 2017 Nov 8. Blood. 2018. PMID: 29118007 Free PMC article. Review.

2

Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers in Lymphoid Malignancies.

Sun R, Wang J, Young KH. Sun R, et al. Crit Rev Oncog. 2017;22(5-6):527-557. doi: 10.1615/CritRevOncog.2017020816. Crit Rev Oncog. 2017. PMID: 29604930 Free PMC article. Review.

3

Genetic alterations and their clinical implications in DLBCL.

Miao Y, Medeiros LJ, Li Y, Li J, Young KH. Miao Y, et al. Nat Rev Clin Oncol. 2019 Oct;16(10):634-652. doi: 10.1038/s41571-019-0225-1. Nat Rev Clin Oncol. 2019. PMID: 31127191 Review.

4

Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma.

Xu-Monette ZY, Wei L, Fang X, Au Q, Nunns H, Nagy M, Tzankov A, Zhu F, Visco C, Bhagat G, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, Hagemeister FB, Sun X, Han X, Go H, Ponzoni M, Ferreri AJM, Møller MB, Parsons BM, van Krieken JH, Piris MA, Winter JN, Li Y, Xu B, Albitar M, You H, Young KH. Xu-Monette ZY, et al. Clin Cancer Res. 2022 Mar 1;28(5):972-983. doi: 10.1158/1078-0432.CCR-21-2949. Clin Cancer Res. 2022. PMID: 34980601 Free PMC article.

5

Therapeutic vaccines for aggressive B-cell lymphoma.

Xu-Monette ZY, Young KH. Xu-Monette ZY, et al. Leuk Lymphoma. 2020 Dec;61(13):3038-3051. doi: 10.1080/10428194.2020.1805113. Epub 2020 Aug 25. Leuk Lymphoma. 2020. PMID: 32840404 Free PMC article.

6

Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma.

Zhang J, Medeiros LJ, Young KH. Zhang J, et al. Front Oncol. 2018 Sep 10;8:351. doi: 10.3389/fonc.2018.00351. eCollection 2018. Front Oncol. 2018. PMID: 30250823 Free PMC article. Review.

7

Checkpoint inhibitors in hematological malignancies.

Ok CY, Young KH. Ok CY, et al. J Hematol Oncol. 2017 May 8;10(1):103. doi: 10.1186/s13045-017-0474-3. J Hematol Oncol. 2017. PMID: 28482851 Free PMC article. Review.

8

Targeting the programmed death-1 pathway in lymphoid neoplasms.

Ok CY, Young KH. Ok CY, et al. Cancer Treat Rev. 2017 Mar;54:99-109. doi: 10.1016/j.ctrv.2017.01.009. Epub 2017 Feb 11. Cancer Treat Rev. 2017. PMID: 28242522 Free PMC article. Review.

9

Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.

Cai Q, Chen K, Young KH. Cai Q, et al. Exp Mol Med. 2015 Jan 23;47(1):e133. doi: 10.1038/emm.2014.105. Exp Mol Med. 2015. PMID: 25613730 Free PMC article. Review.

10

Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.

Sun R, Medeiros LJ, Young KH. Sun R, et al. Mod Pathol. 2016 Oct;29(10):1118-42. doi: 10.1038/modpathol.2016.92. Epub 2016 Aug 1. Mod Pathol. 2016. PMID: 27363492 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

57 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year